Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Experiment Study on the Influence of Density and Confining Pressure on Triaxial Shear Properties of Calcareous Sand. | Materials (Basel) | 2023 | 36837313 | PubTator, text mining | PubMed |
| Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma. | J Pers Med | 2023 | 36836422 | PubTator, text mining | PubMed |
| Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 36835246 | PubTator, text mining | PubMed |
| Methyl Donor Micronutrients: A Potential Dietary Epigenetic Target in Systemic Lupus Erythematosus Patients. | Int J Mol Sci | 2023 | 36834583 | PubTator, text mining | PubMed |
| CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. | Cancers (Basel) | 2023 | 36831514 | PubTator, text mining | PubMed |
| Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study. | Biomedicines | 2023 | 36831046 | PubTator, text mining | PubMed |
| mRNA-From COVID-19 Treatment to Cancer Immunotherapy. | Biomedicines | 2023 | 36830845 | PubTator, text mining | PubMed |
| CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. | Biology (Basel) | 2023 | 36829563 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in orthopedic research. | Bone Res | 2023 | 36828839 | PubTator, text mining | PubMed |
| Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. | Curr Oncol | 2023 | 36826113 | PubTator, text mining | PubMed |
| Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience. | Front Immunol | 2023 | 36825011 | PubTator, text mining | PubMed |
| Treatment of extranodal NK/T-cell lymphoma: From past to future. | Front Immunol | 2023 | 36825002 | PubTator, text mining | PubMed |
| Molecular classification and therapeutics in diffuse large B-cell lymphoma. | Front Mol Biosci | 2023 | 36818048 | PubTator, text mining | PubMed |
| Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials. | Front Immunol | 2023 | 36817443 | PubTator, text mining | PubMed |
| Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis. | Clin Exp Med | 2023 | 36811800 | PubTator, text mining | PubMed |
| Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. | Cancer Immunol Immunother | 2023 | 36811663 | PubTator, text mining | PubMed |
| Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma. | Elife | 2023 | 36811599 | PubTator, text mining | PubMed |
| Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target. | Clin Transl Med | 2023 | 36808888 | PubTator, text mining | PubMed |
| Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology. | Life Sci Alliance | 2023 | 36806094 | PubTator, text mining | PubMed |
| The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma. | BMC Cancer | 2023 | 36797681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=44